Lonza Biologics Plant Expansion, Portsmouth, NH, USA


Eculizumab was approved by the US FDA in March 2007 and acts against complement component C5.



| 1 | 2 | 3 | 4 | 5 |

Browse More Images - Return to Project




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter Sign-Up
Advertise With Us
About Us
Client Area


RSS What is RSS
The website for the pharmaceutical industry